Posts by KCAS Bio
News
In modern bioanalytical research, data quality remains the defining metric of success. At the same time, study complexity continues to increase. KCAS Bio is advancing its global flow cytometry services with a focused strategy that integrates AI-enabled efficiencies, harmonized workflows, and high-parameter technologies. The goal…
Blogs
Some molecules refuse to be easy to study. In this case, the drug was highly charged, sticky, and extremely sensitive to proteolysis, and previous partner labs had already struggled with it; “they’ve never seen anything like this before!” Keeping the entire process, from method transfer, optimization, validation, and…
webinars
Biomarkers can move a program forward fast. Or slow it down with rework. Biomarkers shape decisions from discovery through late-stage clinical trials. But the wrong assay plan can waste time, budget and samples. In this KCAS Bio roundtable, we share practical ways to align context of use,…
Blogs
At KCAS Bio, we supported a therapeutic monoclonal antibody for advanced solid tumors from non-human primate (NHP) toxicology through first-in-human (FIH) dose escalation into phase 2 expansion. This project combined receptor occupancy assays (ROA) by flow cytometry for cell-surface binding on monocytes, immunophenotyping (IPT) for activation markers,…
News
KCAS Bio is proud to announce that its EU site (Lyon, France) has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP), confirming its ability to deliver GLP-grade bioanalytical methods in support of preclinical studies. Our GLP test facility was granted a Level of compliance “A”, reinforcing KCAS Bio’s…
Posters & Papers
Discover in this white paper a global collaboration between KCAS Bio and its strategic partner, Crux Biolabs, to harmonize and validate a standardized 15-color spectral flow cytometry panel for pan-leukocyte profiling across multiple sites. If you have any questions about these services or any others…
April 27
- April 28
KCAS Bio will be attending BioVaria in Munich, on April 27-28, 2026. This event connects leading tech transfer professionals and academic innovators with start-ups and representatives from the global biotech and pharma industry. Supporting Biologics Drug Development KCAS Bio supports small and large molecule drug development across…
March 26
- March 26
KCAS Bio will be attending Innovation for Health in Utrecht, March 26, 2026. This events brings together key players from the Life Sciences & Health ecosystem. Centered on the theme “Bridging the Gap – From Idea to Innovation & from Patent to Patient,” the conference fosters insight sharing, collaboration,…
April 21
- April 22
KCAS Bio will be attending German Biotech Days in Leipzig, on April 21–22, 2026. German Biotech Days (DBT) bring together entrepreneurs, scientists, and key partners from across the biotech ecosystem, including investors, funding institutions, policymakers, and public administration. Supporting Biologics Drug Development KCAS Bio supports small and…
March 24
- March 25
KCAS Bio will be attending NextGen Biomed 2026 in London, on March 24–25, 2026. NextGen Biomed is a long-standing, community-driven platform that brings together the biologics and immunotherapy ecosystem to foster interdisciplinary collaboration and knowledge sharing across the R&D lifecycle. Supporting Biologics Drug Development KCAS Bio supports…
March 24
- March 25
KCAS Bio will be attending Venture Connect in Durham, North Carolina on March 24-25, 2026. This event Brings together 200+ venture firms and capital sources to hear cutting-edge innovation in multiple verticals, and build strategic relationships that drive fundraising and business development. Venture Connect is the Southeast’s premier…
April 30
- April 30
This new symposium series from PBSS will provide important value to life science industry scientists, since much of the R&D work of our industry nowadays is done at the vendors (CROs, CDMOs, tool makers etc). These scientific symposia will present unique technologies and valuable scientific case studies from vendor…